you are here: Home News Maiden Pharmaceuticals

Maiden Pharmaceuticals

Maiden Pharma denies tampering with tests in probe of cough syrup deaths
India probe into bribery claim in toxic syrup tests nears completion
Fresh trouble for tainted pharma firm linked with Gambia deaths in decade-old case
WHO awaits probe by Indian drug regulator to chart the fate of Marion Biotech
What can the inspection of select drugmaking units hope to achieve?
Drug standard watchdog inspects ‘suspicious’ manufacturing units across India
Maiden seeks to reopen plant after India government lab says cough syrups were safe
Gambian children’s death: Maiden Pharma’s cough syrups of standard quality, no contaminants found, says govt
Will proposed drug database resolve lax monitoring of quality?
Gambian children deaths highlight deep rooted malaise in Indian pharma
WHO noncommittal on sharing cough syrup causality assessment report: Govt sources
Post-Gambia deaths, CDSCO and state regulators start testing cough syrups sold in market
Haryana regulator raises red flag over glaring lapses at Maiden Pharma plant
Exclusive | Early probe finds violation in drug manufacturing process by Maiden Pharma
How Maiden and other Indian pharma firms exploited WHO certification process
Maiden Pharma says medicines linked to Gambia child deaths not sold in India
Kerala halts sale of drugs made by Maiden Pharma under fire for children's death in Gambia
Moneycontrol Daily: Your Essential 7
Maiden Pharma’s factory wears a deserted look as its fate hangs in the balance
Govt must fix accountability: Anand Sharma on 'cough syrups-linked' deaths in Gambia
Why Indian regulators fail to prevent fatal lapses in drug manufacturing
Indian pharma company under fire for Gambia child deaths has a history of selling substandard drugs
Moneycontrol Selects: Top stories this evening
Cough syrup deaths: Govt says drugs not permitted for sale in India
India vows action if cough syrup proved to be behind Gambia deaths

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Maiden Pharmaceuticals

Maiden Pharma denies tampering with tests in probe of cough syrup deaths

India probe into bribery claim in toxic syrup tests nears completion

Fresh trouble for tainted pharma firm linked with Gambia deaths in decade-old case

WHO awaits probe by Indian drug regulator to chart the fate of Marion Biotech

What can the inspection of select drugmaking units hope to achieve?

Drug standard watchdog inspects ‘suspicious’ manufacturing units across India

Maiden seeks to reopen plant after India government lab says cough syrups were safe

Gambian children’s death: Maiden Pharma’s cough syrups of standard quality, no contaminants found, says govt

Will proposed drug database resolve lax monitoring of quality?

Gambian children deaths highlight deep rooted malaise in Indian pharma

WHO noncommittal on sharing cough syrup causality assessment report: Govt sources

Post-Gambia deaths, CDSCO and state regulators start testing cough syrups sold in market

Haryana regulator raises red flag over glaring lapses at Maiden Pharma plant

Exclusive | Early probe finds violation in drug manufacturing process by Maiden Pharma

How Maiden and other Indian pharma firms exploited WHO certification process

Maiden Pharma says medicines linked to Gambia child deaths not sold in India

Kerala halts sale of drugs made by Maiden Pharma under fire for children's death in Gambia

Moneycontrol Daily: Your Essential 7

Maiden Pharma’s factory wears a deserted look as its fate hangs in the balance

Govt must fix accountability: Anand Sharma on 'cough syrups-linked' deaths in Gambia

Why Indian regulators fail to prevent fatal lapses in drug manufacturing

Indian pharma company under fire for Gambia child deaths has a history of selling substandard drugs

Moneycontrol Selects: Top stories this evening

Cough syrup deaths: Govt says drugs not permitted for sale in India

India vows action if cough syrup proved to be behind Gambia deaths